Effectiveness of azvudine versus nirmatrelvir/ritonavir for hospitalized patients with SARS-CoV-2 infection and pre-existing liver diseases

Effectiveness of azvudine versus nirmatrelvir/ritonavir for hospitalized patients with SARS-CoV-2 infection and pre-existing liver diseases

Abstract Background Azvudine and nirmatrelvir/ritonavir are recommended as priority treatments for SARS-CoV-2 infection in China, but their effectiveness and safety in patients with pre-existing chronic liver diseases remains unknown. Methods We conducted a multicenter retrospective cohort study of...

Full description

Saved in:
Bibliographic Details
Main Authors: Guanyue Su, Feng Gao, Mengzhao Yang, Ling Wang, Lili Liang, Silin Li, Guangming Li, Na Han, Guotao Li, Guowu Qian, Shixi Zhang, Hong Luo, Donghua Zhang, Hongxia Liang, Zhigang Ren
Format: Article
Language:English
Published: BMC 2025-05-01
Series:Virology Journal
Subjects:
SARS-CoV-2
Azvudine
Paxlovid
Chronic liver disease
Effectiveness
Online Access:https://doi.org/10.1186/s12985-025-02771-1
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12985-025-02771-1

Similar Items